Macao vs Syria: HIV-positive TB patients on ART (antiretroviral therapy)
Macao
100.0%
in 2024
Syria
100.0%
in 2021
Macao rank
1st
Syria rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Macao
- Syria
How they compare
Macao currently reports 100.0% against 100.0% in Syria, a difference of 0.0%.
Across all 10 years both countries report, Syria has been ahead every year.
Macao ranks 1st and Syria ranks 1st of 144 countries.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Macao | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.0% | 100.0% | 75.0% | Syria |
| 2010s | 67.4% | 100.0% | 32.6% | Syria |
| 2020s | 87.5% | 100.0% | 12.5% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Macao or Syria?
- Macao, at 100.0% against 100.0% in Syria as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Macao and Syria?
- 0.0%, with Macao ahead.
- How many years of comparable data are there for Macao and Syria?
- 10 years are reported by both, from 2007 to 2021.
- How do Macao and Syria rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Macao ranks 1st and Syria ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.